Source:http://linkedlifedata.com/resource/pubmed/id/12928523
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2003-8-20
|
pubmed:abstractText |
Mitochondrial dysfunction has been identified as a possible early event in ischemia-reperfusion damage. The peripheral benzodiazepine receptor, a mitochondrial inner membrane protein, has already been proposed to play a role in mitochondrial regulation, although its exact function remains unclear. The aim of this work was to determine the role of peripheral benzodiazepine receptor in ischemia-reperfusion injury and to test the potential beneficial effect of a novel potent peripheral benzodiazepine receptor ligand, 7-chloro-N,N,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4H-pyridazino[4,5-b]indole-1-acetamide (SSR180575). To characterize and link the mitochondrial, cellular, and cardiac consequences of ischemia-reperfusion, we examined the effects of SSR180575 in several in vitro and in vivo models of oxidative stress. Hydrogen peroxide decreased mitochondrial membrane potential, reduced oxidative phosphorylation capacities, and caused cytochrome c release, caspase 3 activation, and DNA fragmentation. SSR180575 (100 nM-1 microM) prevented all these effects. In perfused rat hearts, SSR180575 administered in vitro (100 nM-1 microM) or by oral pretreatment (3-30 mg/kg) greatly reduced the contractile dysfunction associated with ischemia-reperfusion. Furthermore, in anesthetized rats, SSR180575 (3-30 mg/kg p.o.) produced significant reductions in infarct size after coronary artery occlusion/reperfusion. In conclusion, we have demonstrated that peripheral benzodiazepine receptor play a major role in the regulation of cardiac ischemia-reperfusion injury and that SSR180575, a novel peripheral benzodiazepine receptor ligand, is of potential interest in these indications.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0022-3565
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
306
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
828-37
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12928523-Anesthesia,
pubmed-meshheading:12928523-Animals,
pubmed-meshheading:12928523-Apoptosis,
pubmed-meshheading:12928523-Disease Models, Animal,
pubmed-meshheading:12928523-Heart Injuries,
pubmed-meshheading:12928523-Male,
pubmed-meshheading:12928523-Mitochondria, Heart,
pubmed-meshheading:12928523-Myoblasts, Cardiac,
pubmed-meshheading:12928523-Myocardial Infarction,
pubmed-meshheading:12928523-Myocardial Reperfusion Injury,
pubmed-meshheading:12928523-Oxidative Phosphorylation,
pubmed-meshheading:12928523-Oxidative Stress,
pubmed-meshheading:12928523-Rabbits,
pubmed-meshheading:12928523-Rats,
pubmed-meshheading:12928523-Rats, Sprague-Dawley,
pubmed-meshheading:12928523-Receptors, GABA-A,
pubmed-meshheading:12928523-Transfection
|
pubmed:year |
2003
|
pubmed:articleTitle |
Role of peripheral benzodiazepine receptors in mitochondrial, cellular, and cardiac damage induced by oxidative stress and ischemia-reperfusion.
|
pubmed:affiliation |
Sanofi-Synthélabo Research, Toulouse, France.
|
pubmed:publicationType |
Journal Article,
In Vitro
|